ZS Named Leader in IDC MarketScape for Real-World Evidence Platforms
Evanston, Illinois – September 17, 2026 -- ZS has been named a Leader in the IDC MarketScape: Worldwide Life Science R&D RWD/Real-World Evidence for Data Platforms, Technology Solutions, and Consulting Services 2026 Vendor Assessment (IDC #US54122226, August 2026).
The recognition marks ZS's second IDC MarketScape Leader designation in 2026, following its May 2026 placement as a Leader in the Worldwide Life Sciences R&D Strategic Consulting Services assessment (IDC #US53009826).
ZS reports 90% NPS and 97% retention across its real-world data and evidence engagements
IDC's assessment cited ZS's integrated Medical & Evidence practice, which links medical, real-world evidence and health economics and outcomes research (HEOR) strategies to speed decision-making. The firm connects evidence generation directly to downstream dissemination, supporting publications, congress strategies and field medical execution for life sciences clients.